Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Peter Vogt

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Neoplastic Cell Transformation

Anatomy

Chemicals & Drugs

Concepts & Ideas

Molecular Sequence Data

Physiology

Genes & Molecular Sequences

Living Beings

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
Aoki, Masahiro
11
Bader, Andreas
11
Kang, Sohye
9
Iacovoni, Jason
8
Kruse, Ulrich
6
Jiang, Bing-Hua
5
Gymnopoulos, Marco
5
Chang, Hwai Wen
4
Zheng, Jenny
3
Tjian, Robert
3
Maslyar, Daniel
3
Sonderegger, Corinna
3
Tsichlis, Philip
3
Boger, Dale
3
Bottoli, I

Sign-in to see all Coauthors

Publications

TOP 3
Bai Dong; Ueno Lynn; Vogt Peter K
Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.
Shi Jin; Stover James S; Whitby Landon R; Vogt Peter K; Boger Dale L
Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation.
Shi Jin; Vogt Peter K
Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Peter Vogt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bai Dong; Ueno Lynn; Vogt Peter K
Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.
International journal of cancer. Journal international du cancer 2009;125(12):2863-70.
2009: Shi Jin; Stover James S; Whitby Landon R; Vogt Peter K; Boger Dale L
Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation.
Bioorganic & medicinal chemistry letters 2009;19(21):6038-41.
2009: Shi Jin; Vogt Peter K
Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein.
International journal of cancer. Journal international du cancer 2009;125(7):1558-65.
2009: Jiang Hao; Bower Kristen E; Beuscher Albert E; Zhou Bin; Bobkov Andrey A; Olson Arthur J; Vogt Peter K
Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function.
Molecular pharmacology 2009;76(3):491-502.
2009: Denley Adam; Gymnopoulos Marco; Kang Sohye; Mitchell Christina; Vogt Peter K
Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.
Molecular cancer research : MCR 2009;7(7):1132-8.
2009: Shaginian Alex; Whitby Landon R; Hong Sukwon; Hwang Inkyu; Farooqi Bilal; Searcey Mark; Chen Jiandong; Vogt Peter K; Boger Dale L
Design, Synthesis, and Evaluation of an alpha-Helix Mimetic Library Targeting Protein-Protein Interactions.
Journal of the American Chemical Society 2009;131(15):5564-72.
2009: Vogt Peter K; Gymnopoulos Marco; Hart Jonathan R
PI 3-kinase and cancer: changing accents.
Current opinion in genetics & development 2009;19(1):12-7.
2009: Vogt Peter K; Hart Jonathan R
Akt demoted in glioblastoma.
Science signaling 2009;2(67):pe26.
2008: Zhao L; Vogt P K
Class I PI3K in oncogenic cellular transformation.
Oncogene 2008;27(41):5486-96.
2008: Jiang H; Vogt P K
Constitutively active Rheb induces oncogenic transformation.
Oncogene 2008;27(43):5729-40.
2008: Vogt Peter K
Drug-resistant phosphatidylinositol 3-kinase: guidance for the preemptive strike.
Cancer cell 2008;14(2):107-8.
2008: Denley A; Kang S; Karst U; Vogt P K
Oncogenic signaling of class I PI3K isoforms.
Oncogene 2008;27(18):2561-74.
2008: Zhao Li; Vogt Peter K
Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(7):2652-7.
2008: Bader A G; Vogt P K
Phosphorylation by Akt disables the anti-oncogenic activity of YB-1.
Oncogene 2008;27(8):1179-82.
2008: Denley Adam; Gymnopoulos Marco; Hart Jonathan R; Jiang Hao; Zhao Li; Vogt Peter K
Biochemical and biological characterization of tumor-associated mutations of p110alpha.
Methods in enzymology 2008;438():291-305.
2007: Vogt Peter K; Kang Sohye; Elsliger Marc-André; Gymnopoulos Marco
Cancer-specific mutations in phosphatidylinositol 3-kinase.
Trends in biochemical sciences 2007;32(7):342-9.
2007: Denning G; Jean-Joseph B; Prince C; Durden D L; Vogt P K
A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
Oncogene 2007;26(27):3930-40.
2007: Gymnopoulos Marco; Elsliger Marc-André; Vogt Peter K
Rare cancer-specific mutations in PIK3CA show gain of function.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(13):5569-74.
2006: Sawa Masaaki; Hsu Tsui-Ling; Itoh Takeshi; Sugiyama Masakazu; Hanson Sarah R; Vogt Peter K; Wong Chi-Huey
Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(33):12371-6.
2006: Vogt Peter K; Kang Sohye
Kinase inhibitors: vice becomes virtue.
Cancer cell 2006;9(5):327-8.
2006: Vogt Peter K; Bader Andreas G; Kang Sohye
PI 3-kinases: hidden potentials revealed.
Cell cycle (Georgetown, Tex.) 2006;5(9):946-9.
2006: Xu Yang; Shi Jin; Yamamoto Noboru; Moss Jason A; Vogt Peter K; Janda Kim D
A credit-card library approach for disrupting protein-protein interactions.
Bioorganic & medicinal chemistry 2006;14(8):2660-73.
2006: Kang Sohye; Denley Adam; Vanhaesebroeck Bart; Vogt Peter K
Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(5):1289-94.
2006: Bader Andreas G; Kang Sohye; Vogt Peter K
Cancer-specific mutations in PIK3CA are oncogenic in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(5):1475-9.
2006: Vogt Peter K; Bader Andreas G; Kang Sohye
Phosphoinositide 3-kinase: from viral oncoprotein to drug target.
Virology 2006;344(1):131-8.
2005: Bader Andreas G; Kang Sohye; Zhao Li; Vogt Peter K
Oncogenic PI3K deregulates transcription and translation.
Nature reviews. Cancer 2005;5(12):921-9.
2005: Vogt Peter K; Bader Andreas G
Jun: stealth, stability, and transformation.
Molecular cell 2005;19(4):432-3.
2005: Vogt Peter K; Jiang Hao; Aoki Masahiro
Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.
Cell cycle (Georgetown, Tex.) 2005;4(7):908-13.
2005: Kang Sohye; Bader Andreas G; Zhao Li; Vogt Peter K
Mutated PI 3-kinases: cancer targets on a silver platter.
Cell cycle (Georgetown, Tex.) 2005;4(4):578-81.
2005: Bader Andreas G; Vogt Peter K
Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.
Molecular and cellular biology 2005;25(6):2095-106.
2005: Kang Sohye; Bader Andreas G; Vogt Peter K
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(3):802-7.
2004: Aoki Masahiro; Jiang Hao; Vogt Peter K
Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(37):13613-7.
2004: Iacovoni Jason S; Cohen Steven B; Berg Thorsten; Vogt Peter K
v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype.
Oncogene 2004;23(33):5703-6.
2004: Bader Andreas G; Vogt Peter K
An essential role for protein synthesis in oncogenic cellular transformation.
Oncogene 2004;23(18):3145-50.
2004: Aoki M; Vogt P K
Retroviral oncogenes and TOR.
Current topics in microbiology and immunology 2004;279():321-38.
2003: Bader Andreas G; Felts Katherine A; Jiang Ning; Chang Hwai Wen; Vogt Peter K
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(21):12384-9.
2003: Nishizawa Makoto; Fu Shu-Ling; Kataoka Kohsuke; Vogt Peter K
Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation.
Oncogene 2003;22(39):7931-41.
2003: Nishizawa Makoto; Kataoka Kohsuke; Vogt Peter K
MafA has strong cell transforming ability but is a weak transactivator.
Oncogene 2003;22(39):7882-90.
2003: Blazek Erik; Wasmer Sibylle; Kruse Ulrich; Aronheim Ami; Aoki Masahiro; Vogt Peter K
Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
Oncogene 2003;22(14):2151-9.
2003: Sonderegger Corinna K; Narisawa-Saito Mako; Vogt Peter K
The C-terminal region of cellular Qin oligomerizes: correlation with oncogenic transformation and transcriptional repression.
Oncogene 2003;22(13):1908-15.
2003: Sonderegger Corinna K; Vogt Peter K
Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts.
Oncogene 2003;22(12):1749-57.
2002: Aoki Masahiro; Sobek Vera; Maslyar Daniel J; Hecht Andreas; Vogt Peter K
Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes.
Oncogene 2002;21(46):6983-91.
2002: Vogt Peter K
Fortuitous convergences: the beginnings of JUN.
Nature reviews. Cancer 2002;2(6):465-9.
2002: Berg Thorsten; Cohen Steven B; Desharnais Joel; Sonderegger Corinna; Maslyar Daniel J; Goldberg Joel; Boger Dale L; Vogt Peter K
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(6):3830-5.
2001: Maslyar D J; Aoki M; Vogt P K
The growth-promoting activity of the Bad protein in chicken embryo fibroblasts requires binding to protein 14-3-3.
Oncogene 2001;20(37):5087-92.
2001: Mende I; Malstrom S; Tsichlis P N; Vogt P K; Aoki M
Oncogenic transformation induced by membrane-targeted Akt2 and Akt3.
Oncogene 2001;20(32):4419-23.
2001: Jiang B H; Jiang G; Zheng J Z; Lu Z; Hunter T; Vogt P K
Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2001;12(7):363-9.
2001: Vogt P K
Jun, the oncoprotein.
Oncogene 2001;20(19):2365-77.
2001: Cohen S B; Waha A; Gelman I H; Vogt P K
Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Oncogene 2001;20(2):141-6.
2001: Aoki M; Blazek E; Vogt P K
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(1):136-41.
2000: Li Y; Jiang B; Ensign W Y; Vogt P K; Han J
Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase.
Cellular signalling 2000;12(11-12):751-7.
2000: Xia Y; Papalopulu N; Vogt P K; Li J
The oncogenic potential of the high mobility group box protein Sox3.
Cancer research 2000;60(22):6303-6.
2000: Ma Y; Geerdes D W; Vogt P K
Oncogenic transformation by the FOX protein Qin requires DNA binding.
Oncogene 2000;19(42):4815-21.
2000: Xia Y; Zhang Z; Kruse U; Vogt P K; Li J
The new serine-threonine kinase, Qik, is a target of the Qin oncogene.
Biochemical and biophysical research communications 2000;276(2):564-70.
2000: Fu S L; Waha A; Vogt P K
Identification and characterization of genes upregulated in cells transformed by v-Jun.
Oncogene 2000;19(31):3537-45.
2000: Clark W; Black E J; MacLaren A; Kruse U; LaThangue N; Vogt P K; Gillespie D A
v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Molecular and cellular biology 2000;20(7):2529-42.
2000: Aoki M; Schetter C; Himly M; Batista O; Chang H W; Vogt P K
The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity.
The Journal of biological chemistry 2000;275(9):6267-75.
2000: Jiang B H; Zheng J Z; Aoki M; Vogt P K
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1749-53.
1999: Kempf B E; Vogt P K
A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(12):813-8.
1999: Vogt P K; Aoki M; Bottoli I; Chang H W; Fu S; Hecht A; Iacovoni J S; Jiang B H; Kruse U
A random walk in oncogene space: the quest for targets.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(12):777-84.
1999: Fu S l; Bottoli I; Goller M; Vogt P K
Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(10):5716-21.
1999: Jiang B H; Aoki M; Zheng J Z; Li J; Vogt P K
Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2077-81.
1999: Aoki M; Hecht A; Kruse U; Kemler R; Vogt P K
Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(1):139-44.
1998: Aoki M; Batista O; Bellacosa A; Tsichlis P; Vogt P K
The akt kinase: molecular determinants of oncogenicity.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(25):14950-5.
1998: Jiang B H; Zheng J Z; Vogt P K
An essential role of phosphatidylinositol 3-kinase in myogenic differentiation.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14179-83.
1998: Himly M; Foster D N; Bottoli I; Iacovoni J S; Vogt P K
The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses.
Virology 1998;248(2):295-304.
1998: Goller M E; Iacovoni J S; Vogt P K; Kruse U
Glutaredoxin is a direct target of oncogenic jun.
Oncogene 1998;16(22):2945-8.
1997: Vogt P K; Li J; Freyaldenhoven B S
Revelations of a captive: retroviral Qin and the oncogenicity of winged helix proteins.
Virology 1997;238(1):1-7.
1997: Kruse U; Iacovoni J S; Goller M E; Vogt P K
Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12396-400.
1997: Li J; Thurm H; Chang H W; Iacovoni J S; Vogt P K
Oncogenic transformation induced by the Qin protein is correlated with transcriptional repression.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(20):10885-8.
1997: Freyaldenhoven B S; Freyaldenhoven M P; Iacovoni J S; Vogt P K
Avian winged helix proteins CWH-1, CWH-2 and CWH-3 repress transcription from Qin binding sites.
Oncogene 1997;15(4):483-8.
1997: Chang H W; Aoki M; Fruman D; Auger K R; Bellacosa A; Tsichlis P N; Cantley L C; Roberts T M; Vogt P K
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase.
Science (New York, N.Y.) 1997;276(5320):1848-50.
1997: Freyaldenhoven B S; Freyaldenhoven M P; Iacovoni J S; Vogt P K
Aberrant cell growth induced by avian winged helix proteins.
Cancer research 1997;57(1):123-9.
1996: Gao M; Morgan I; Vogt P K
Differential and antagonistic effects of v-Jun and c-Jun.
Cancer research 1996;56(18):4229-35.
1996: Chang H W; Li J; Vogt P K
Domains of the qin protein required for oncogenic transformation.
Oncogene 1996;13(2):441-4.
1996: Liu C; Smith B M; Ajito K; Komatsu H; Gomez-Paloma L; Li T; Theodorakis E A; Nicolaou K C; Vogt P K
Sequence-selective carbohydrate-DNA interaction: dimeric and monomeric forms of the calicheamicin oligosaccharide interfere with transcription factor function.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(2):940-4.
1995: Li J; Chang H W; Lai E; Parker E J; Vogt P K
The oncogene qin codes for a transcriptional repressor.
Cancer research 1995;55(23):5540-4.
1995: Schuur E R; Kruse U; Iacovoni J S; Vogt P K
Nuclear factor I interferes with transformation induced by nuclear oncogenes.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(3):219-27.
1995: Vogt P K
The story of Jun.
Archives of biochemistry and biophysics 1995;316(1):1-4.
1994: Morgan I M; Håvarstein L S; Wong W Y; Luu P; Vogt P K
Efficient induction of fibrosarcomas by v-jun requires mutations in the DNA binding region and the transactivation domain.
Oncogene 1994;9(10):2793-7.
1993: Schuur E R; Parker E J; Vogt P K
Chimeras of herpes simplex viral VP16 and jun are oncogenic.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(9):761-8.
1993: Monteclaro F S; Vogt P K
A Jun-binding protein related to a putative tumor suppressor.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(14):6726-30.
1993: Morgan I M; Asano M; Håvarstein L S; Ishikawa H; Hiiragi T; Ito Y; Vogt P K
Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
Oncogene 1993;8(5):1135-40.
1993: Li J; Vogt P K
The retroviral oncogene qin belongs to the transcription factor family that includes the homeotic gene fork head.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(10):4490-4.
1993: Vogt P K
Cancer genes.
The Western journal of medicine 1993;158(3):273-8.
1993: Vanhamme L; Marshall G M; Schuh A C; Breitman M L; Vogt P K
Tumor necrosis factor alpha and interleukin 1 alpha induce anchorage independence in v-jun transgenic murine cells.
Cancer research 1993;53(3):615-21.
1992: Hartl M; Vogt P K
A rearranged junD transforms chicken embryo fibroblasts.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1992;3(12):909-18.
1992: Hartl M; Vogt P K
Oncogenic transformation by Jun: role of transactivation and homodimerization.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1992;3(12):899-908.
1992: Wong W Y; Håvarstein L S; Morgan I M; Vogt P K
c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic.
Oncogene 1992;7(10):2077-80.
1992: Morgan I M; Ransone L J; Bos T J; Verma I M; Vogt P K
Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Oncogene 1992;7(6):1119-25.
1992: Chida K; Vogt P K
Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(10):4290-4.
1992: Vogt P K
Charles S. Mott Prize. Jun: a transcription factor becomes oncogenic.
Cancer 1992;69(10):2610-4.
1992: Marshall G M; Vanhamme L; Wong W Y; Su H; Vogt P K
Wounding acts as a tumor promoter in chickens inoculated with avian sarcoma virus 17.
Virology 1992;188(1):373-7.
1992: Håvarstein L S; Morgan I M; Wong W Y; Vogt P K
Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(2):618-22.
1992: Vogt P K; Morgan I M; Håvarstein L; Su H; Hartl M; Schuur E
The oncogenicity of Jun.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 3():184S-186S.
1991: Vogt P K
The first family of oncogenes: appreciation of a Japanese contribution.
Japanese journal of cancer research : Gann 1991;82(12):1456-7.
1991: Su H Y; Bos T J; Monteclaro F S; Vogt P K
Jun inhibits myogenic differentiation.
Oncogene 1991;6(10):1759-66.
1991: Hartl M; Hutchins J T; Vogt P K
The chicken junD gene and its product.
Oncogene 1991;6(9):1623-31.
1990: Bos T J; Monteclaro F S; Mitsunobu F; Ball A R; Chang C H; Nishimura T; Vogt P K
Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences.
Genes & development 1990;4(10):1677-87.
1990: Schuh A C; Keating S J; Monteclaro F S; Vogt P K; Breitman M L
Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice.
Nature 1990;346(6286):756-60.
1990: Vogt P K; Morgan I
The genetics of jun.
Seminars in cancer biology 1990;1(1):27-36.
1990: Vogt P K; Bos T J
jun: oncogene and transcription factor.
Advances in cancer research 1990;55():1-35.
1989: Tsuchie H; Chang C H; Yoshida M; Vogt P K
A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene.
Oncogene 1989;4(11):1281-4.
1989: Bos T J; Rauscher F J; Curran T; Vogt P K
The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.
Oncogene 1989;4(2):123-6.
1989: Sharma A; Bos T J; Pekkala-Flagan A; Vogt P K; Lee A S
Interaction of cellular factors related to the Jun oncoprotein with the promoter of a replication-dependent hamster histone H3.2 gene.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(2):491-5.
1989: Vogt P K; Bos T J; Mitsunobu F; Nishimura T; Monteclaro F S; Su H Y
The oncogenicity of jun.
Princess Takamatsu symposia 1989;20():127-34.
1988: Nishimura T; Vogt P K
The avian cellular homolog of the oncogene jun.
Oncogene 1988;3(6):659-63.
1988: Rauscher F J; Cohen D R; Curran T; Bos T J; Vogt P K; Bohmann D; Tjian R; Franza B R
Fos-associated protein p39 is the product of the jun proto-oncogene.
Science (New York, N.Y.) 1988;240(4855):1010-6.
1988: Bos T J; Bohmann D; Tsuchie H; Tjian R; Vogt P K
v-jun encodes a nuclear protein with enhancer binding properties of AP-1.
Cell 1988;52(5):705-12.
1988: Ball A R; Bos T J; Löliger C; Nagata L P; Nishimura T; Su H; Tsuchie H; Vogt P K
Jun: oncogene and transcriptional regulator.
Cold Spring Harbor symposia on quantitative biology 1988;53 Pt 2():687-93.
1987: Bohmann D; Bos T J; Admon A; Nishimura T; Vogt P K; Tjian R
Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.
Science (New York, N.Y.) 1987;238(4832):1386-92.
1986: Bos T J; Beug H; Graf T; Hayman M; Maki Y; Uckert W; Vogt P K
Two new retroviral onc genes, sea and jun.
Princess Takamatsu symposia 1986;17():23-30.

Sign-in to see more